Table 2.
Logistic regression models comparing incidence of symptoms for clopidogrel/Sex/Age in IBS patients
| Odds ratio | 95% CI | p value | ||
|---|---|---|---|---|
| Naïve clopidogrel versus no-clopidogrel group | 1.4 | 1.14 | 1.72 | <0.0011 |
| Clopidogrel versus no-clopidogrel (adjusted for Age and Sex) | 1.75* | 1.42 | 2.15 | <0.0001 |
| Sex differences (Female vs. Male) after adjusting for clopidogrel and Age | 1.01 | 0.90 | 1.14 | 0.8356 |
| Age as a continuous variable (adjusted for clopidogrel and Sex) | 0.99* | 0.98 | 0.99 | <0.0001 |
| Females only | ||||
| Clopidogrel versus no-clopidogrel | 1.98* | 1.55 | 2.53 | <0.0001 |
| Age | 0.98* | 0.98 | 0.99 | <0.0001 |
| Males only | ||||
| Clopidogrel versus no-clopidogrel | 1.18 | 0.79 | 1.78 | 0.4137 |
| Age | 0.99* | 0.99 | 1.00 | 0.0072 |
CI confidence interval
The difference is significant